Mirador Nabs EU Approval

Xconomy Seattle — 

Seattle-based Mirador Biomedical, the developer of a device to prevent dangerous bleeding episodes in hospitals, said today it has gotten clearance from regulators to start selling the product in the European Union. The company won FDA approval last October, and since then, its device has been used in more than 2,000 procedures in more than 50 U.S. hospitals, who are looking to avoid mistaken insertions of catheters into the wrong kind of blood vessel.”With U.S. sales picking up briskly, we look forward to expanding our commercialization effort in the EU,” said Mirador CEO Karl Schmidt, in a statement.